Virginia Commonwealth University clinical trial pipeline

10 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 5 with minor changes only.

1. Notable

   Virtual Reality Brief Violence Intervention: Preventing Gun…Virtual Reality Brief Violence Intervention: Preventing Gun Violence Among Violently Injured Adults

   Primary completion pushed from Sep 2026 to Sep 29, 2027

   Also in this update: Study completion pushed from Oct 2026 to Oct 2027

   Virginia Commonwealth University·Not applicable· NCT06239285· Registry history of NCT06239285 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

2. Notable

   Violence Prevention Strategies to Prevent and Reduce Community…Violence Prevention Strategies to Prevent and Reduce Community Levels of Youth Violence

   Primary and study completion pushed from Aug 30, 2026 to Feb 28, 2027

   Virginia Commonwealth University·Not applicable· NCT06176300· Registry history of NCT06176300 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

3. Notable

   Impact of Exercise Training on Vascular Dysfunction · Mental…Impact of Exercise Training on Vascular Dysfunction · Mental Health Disorders - Study 1

   Primary and study completion pushed from Aug 2026 to Aug 2027

   Virginia Commonwealth University·Not applicable· NCT04916327· Registry history of NCT04916327 on ClinicalTrials.gov (opens the registry)

   Updated Sep 23, 2026

4. Notable

   Cardiovascular Health Education Via Virtual Reality for Breast…Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

   Primary completion pushed from Jul 30, 2026 to Jul 30, 2027

   Also in this update: Study completion pushed from Feb 28, 2027 to Sep 28, 2027

   Virginia Commonwealth University·Not applicable· NCT07426913· Registry history of NCT07426913 on ClinicalTrials.gov (opens the registry)

   Updated Sep 22, 2026

5. Notable

   Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML…Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN

   Recruitment opened

   Virginia Commonwealth University·Phase 2· NCT07710534· Registry history of NCT07710534 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.